Brief: Journey Medical Announces Settlement Agreements Pertaining To Qbrexza, Amzeeq And Zilxi Patent Exclusivity
24/05/2022 13:40
May 24 (Reuters) - Journey Medical Corp DERM.O :
* JOURNEY MEDICAL CORPORATION ANNOUNCES SETTLEMENT
AGREEMENTS
PERTAINING TO QBREXZA®, AMZEEQ® AND ZILXI® PATENT EXCLUSIVITY
* JOURNEY MEDICAL - PADAGIS WILL NOT BE ALLOWED TO LAUNCH
GENERIC
VERSIONS OF QBREXZA, AMZEEQ, ZILXI UNTIL AUG 15, 2030, JULY 1,
2031, APRIL 1, 2027, RESPECTIVELY
Source text for Eikon: ID:nGNX6CPr23
Further company coverage: DERM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Journey Medical
See all newsJourney Medical Corp expected to post a loss of 1 cent a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
U.S. STOCKS ON THE MOVE-Five Below, Salesforce, IBM, Akamai Technologies